Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-05-003149
Filing Date
2005-03-28
Accepted
2005-03-28 17:29:09
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 INHIBITEX, INC. g94018e10vk.htm 10-K 909008
2 EX-10.40 LOAN AGREEMENT DATED DECEMBER 28, 2004 g94018exv10w40.txt EX-10.40 30644
3 EX-23.1 CONSENT OF ERNST & YOUNG LLP g94018exv23w1.txt EX-23.1 575
4 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g94018exv31w1.txt EX-31.1 3479
5 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g94018exv31w2.txt EX-31.2 3526
6 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO & CFO g94018exv32w1.txt EX-32.1 1332
  Complete submission text file 0000950144-05-003149.txt   950825
Mailing Address 1165 SANCTUARY PARKWAY SUITE 400 ALPHARETTA GA 30004
Business Address 1165 SANCTUARY PARKWAY SUITE 400 ALPHARETTA GA 30004 678-746-1100
INHIBITEX INC (Filer) CIK: 0001274913 (see all company filings)

EIN.: 742708737
Type: 10-K | Act: 34 | File No.: 000-50772 | Film No.: 05707448
SIC: 2836 Biological Products, (No Diagnostic Substances)